Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 11 | 2024 | 843 | 2.440 |
Why?
|
| Death, Sudden | 3 | 2018 | 44 | 1.180 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2020 | 84 | 0.740 |
Why?
|
| Brain Stem | 2 | 2020 | 109 | 0.710 |
Why?
|
| Epilepsy, Generalized | 2 | 2020 | 61 | 0.700 |
Why?
|
| Spasms, Infantile | 1 | 2022 | 165 | 0.670 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 191 | 0.600 |
Why?
|
| RNA Splicing | 1 | 2020 | 231 | 0.590 |
Why?
|
| Genetic Variation | 2 | 2023 | 1520 | 0.570 |
Why?
|
| Autonomic Nervous System | 1 | 2018 | 46 | 0.570 |
Why?
|
| Epilepsies, Partial | 5 | 2020 | 84 | 0.500 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 537 | 0.490 |
Why?
|
| Sudden Infant Death | 1 | 2016 | 32 | 0.470 |
Why?
|
| Heart Rate | 1 | 2018 | 565 | 0.460 |
Why?
|
| Cognition Disorders | 1 | 2018 | 542 | 0.440 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 523 | 0.440 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 1099 | 0.420 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 270 | 0.400 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2018 | 474 | 0.390 |
Why?
|
| Heterozygote | 3 | 2020 | 690 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 3679 | 0.330 |
Why?
|
| Neurons | 1 | 2020 | 1919 | 0.330 |
Why?
|
| Electric Stimulation Therapy | 2 | 2020 | 80 | 0.280 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 708 | 0.240 |
Why?
|
| Intellectual Disability | 2 | 2020 | 1045 | 0.240 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2020 | 248 | 0.230 |
Why?
|
| Seizures | 2 | 2020 | 848 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 362 | 0.210 |
Why?
|
| Empiricism | 1 | 2023 | 1 | 0.210 |
Why?
|
| Electrocorticography | 1 | 2024 | 55 | 0.200 |
Why?
|
| Chromosome Deletion | 1 | 2006 | 643 | 0.190 |
Why?
|
| Glycosylation | 1 | 2022 | 111 | 0.190 |
Why?
|
| Child, Preschool | 5 | 2020 | 14330 | 0.180 |
Why?
|
| Electroencephalography | 3 | 2024 | 820 | 0.180 |
Why?
|
| Humans | 19 | 2024 | 126020 | 0.180 |
Why?
|
| Deep Brain Stimulation | 2 | 2017 | 402 | 0.170 |
Why?
|
| Young Adult | 7 | 2020 | 9615 | 0.160 |
Why?
|
| Implantable Neurostimulators | 1 | 2020 | 21 | 0.160 |
Why?
|
| Axon Guidance | 1 | 2020 | 4 | 0.160 |
Why?
|
| Infant | 4 | 2018 | 12762 | 0.160 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 965 | 0.160 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 2 | 2018 | 15 | 0.160 |
Why?
|
| Dynamins | 1 | 2019 | 44 | 0.150 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 188 | 0.150 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2018 | 25 | 0.150 |
Why?
|
| Language Development Disorders | 1 | 2020 | 177 | 0.150 |
Why?
|
| Channelopathies | 1 | 2018 | 12 | 0.140 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 5049 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2020 | 298 | 0.140 |
Why?
|
| Adolescent | 8 | 2020 | 19936 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2020 | 648 | 0.140 |
Why?
|
| Atrophy | 1 | 2018 | 236 | 0.140 |
Why?
|
| Zebrafish | 1 | 2020 | 401 | 0.130 |
Why?
|
| Adult | 10 | 2020 | 30235 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2898 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2023 | 1060 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2019 | 283 | 0.130 |
Why?
|
| Neocortex | 1 | 2017 | 67 | 0.120 |
Why?
|
| ERG1 Potassium Channel | 1 | 2016 | 3 | 0.120 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2016 | 5 | 0.120 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2016 | 11 | 0.120 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2016 | 13 | 0.120 |
Why?
|
| Male | 11 | 2020 | 62050 | 0.120 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2016 | 35 | 0.120 |
Why?
|
| Base Sequence | 1 | 2020 | 2770 | 0.120 |
Why?
|
| Female | 12 | 2020 | 67877 | 0.120 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2016 | 39 | 0.120 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2015 | 62 | 0.110 |
Why?
|
| Potassium Channels | 1 | 2016 | 152 | 0.110 |
Why?
|
| Brain Waves | 1 | 2015 | 43 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2015 | 172 | 0.110 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 441 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 609 | 0.100 |
Why?
|
| Brain Chemistry | 1 | 2013 | 111 | 0.100 |
Why?
|
| Chloride Channels | 1 | 2013 | 60 | 0.100 |
Why?
|
| Child | 4 | 2018 | 25061 | 0.090 |
Why?
|
| Quality of Life | 1 | 2020 | 2023 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2011 | 190 | 0.080 |
Why?
|
| Middle Aged | 6 | 2020 | 27300 | 0.070 |
Why?
|
| Brain Mapping | 2 | 2024 | 369 | 0.070 |
Why?
|
| Ethics, Medical | 1 | 2011 | 399 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3904 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2011 | 526 | 0.060 |
Why?
|
| Electrodes, Implanted | 2 | 2017 | 168 | 0.060 |
Why?
|
| Mice | 2 | 2020 | 17574 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3256 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2318 | 0.050 |
Why?
|
| Video Recording | 1 | 2006 | 200 | 0.050 |
Why?
|
| Genomics | 1 | 2011 | 1570 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 1066 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2018 | 16753 | 0.050 |
Why?
|
| Benchmarking | 1 | 2024 | 129 | 0.050 |
Why?
|
| Syndrome | 1 | 2006 | 1133 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2019 | 889 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2006 | 548 | 0.040 |
Why?
|
| Animals | 2 | 2020 | 33114 | 0.040 |
Why?
|
| Societies | 1 | 2020 | 21 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2022 | 349 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 69 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 41 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 224 | 0.040 |
Why?
|
| Histones | 1 | 2022 | 505 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2020 | 151 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2020 | 207 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 156 | 0.040 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 176 | 0.040 |
Why?
|
| Suicide | 1 | 2020 | 201 | 0.030 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2017 | 3 | 0.030 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2017 | 14 | 0.030 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2017 | 16 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 6085 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2020 | 460 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 209 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2022 | 1036 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 278 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 1173 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1611 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 788 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 731 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 19973 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12310 | 0.020 |
Why?
|
| Brain | 1 | 2024 | 3032 | 0.020 |
Why?
|
| Consent Forms | 1 | 2011 | 22 | 0.020 |
Why?
|
| Genetic Privacy | 1 | 2011 | 41 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 231 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1572 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1421 | 0.020 |
Why?
|
| Hippocampus | 1 | 2015 | 775 | 0.020 |
Why?
|
| Informed Consent | 1 | 2011 | 336 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2011 | 362 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2547 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 6006 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 1279 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 4914 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6543 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 2847 | 0.010 |
Why?
|